Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Hycienth Ahaneku"'
Publikováno v:
Journal of Public Health in Africa, Vol 5, Iss 1 (2014)
The vision of Nigeria’s immunization program is to reach and sustain routine immunization coverage of greater than 90% for all vaccines by 2020. In order to achieve this, Abia state embarked on a unique private-public partnership (PPP) between priv
Externí odkaz:
https://doaj.org/article/dc00d2c99a4a4f69b32caaab3696dc8d
Autor:
Kadhim Al-Banaa, Emma Herrman, Bana Antonios, Hycienth Ahaneku, Shiva Shrotriya, Can Wang, Daniel E Ezekwudo, Ishmael Jaiyesimi
Publikováno v:
Blood. 140:2795-2796
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5e5852bb31d9eb1c3514e2af5bd8d97
https://doi.org/10.1182/blood-2022-157217
https://doi.org/10.1182/blood-2022-157217
Autor:
Hycienth Ahaneku, MD DrPH, Chukwuemeka A. Umeh, MD DrPH, Mike Cao, MD, Bradley Kapten, MD, Baher Elhalwagi, MD, Tiffany Egbe, MD, Emmanuel Elueze, MD, PhD
Publikováno v:
International Journal of Innovative Research in Medical Science. 5:395-399
Background: In the face of antibiotics resistance and adverse effects, emerging evidence suggests that procalcitonin guided therapy can help enhance appropriate use of antibiotics especially in patients with respiratory infections and sepsis. We seek
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98314e3c433fa9d93d870d1688ad6587
https://doi.org/10.23958/ijirms/vol05-i09/947
https://doi.org/10.23958/ijirms/vol05-i09/947
Autor:
Luai Madanat, Ruby Gupta, Paul Weber, Navneet Kumar, Rohit Chandra, Hycienth Ahaneku, Yatharth Bansal, Joseph Anderson, Abhay Bilolikar, Ishmael Jaiyesimi
Publikováno v:
Current cardiology reviews.
Abstract: Cardiotoxicity from chemotherapy regimens has been long reported. However, the understanding of cardiac side effects of biological therapies is rapidly evolving. With cancer patients achieving higher life expectancy due to the use of person
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bec5c69ea8e1a5d3fd7c3d3b2f89906
https://pubmed.ncbi.nlm.nih.gov/35642110
https://pubmed.ncbi.nlm.nih.gov/35642110
Autor:
Elli Novatcheva, Chukwuemeka A. Umeh, Adrian Davoodian, Hycienth Ahaneku, Ankur Kundu, Gabriela P. Sassi
Publikováno v:
Cureus
Immune thrombocytopenia, also called idiopathic thrombocytopenic purpura, is a common cause of thrombocytopenia after viral infections. Even in the second year of the coronavirus disease 2019 (COVID-19) pandemic, our body of knowledge regarding the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d03403fb3244a618744be378a2f01246
http://europepmc.org/articles/PMC8668258
http://europepmc.org/articles/PMC8668258
Autor:
Susan O'Brien, Graciela M. Nogueras-Gonzalez, Guillermo Garcia-Manero, Zeev Estrov, Srdan Verstovsek, Farhad Ravandi, Princy Yohannan Sam, Koji Sasaki, Preetesh Jain, Elias Jabbour, Prajwal C. Boddu, Tapan M. Kadia, Hycienth Ahaneku, Gautam Borthakur, Hagop M. Kantarjian, Jorge E. Cortes
Publikováno v:
Blood Advances. 3:851-861
Cardiovascular or arteriothrombotic adverse events (CV- or AT-AEs) are reported in chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs). The incidence and characteristics across different TKI have not been systematic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1491166afe254b8ba8f32e885418610
https://doi.org/10.1182/bloodadvances.2018025874
https://doi.org/10.1182/bloodadvances.2018025874
Autor:
Markie Sue Zimmer, Michael Stender, Ishmael Jaiyesimi, Nwabundo Anusim, Hycienth Ahaneku, Filip Ionescu, Marianne Terese Huben
Publikováno v:
Blood. 138:3088-3088
Introduction: The presence of hetero- (sickle trait) or homozygous (sickle disease) hemoglobin S gene is associated with increased risk of venous thromboembolism (VTE). However, sickle disease patients in particular are relatively young, lack common
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fb1bb000347083f7a0417eef149805a
https://doi.org/10.1182/blood-2021-144719
https://doi.org/10.1182/blood-2021-144719
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92736c70c15422f1696eae6dc14bd34c
https://doi.org/10.1016/s2152-2650(21)01371-9
https://doi.org/10.1016/s2152-2650(21)01371-9
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S310
Introduction: Hyperbaric oxygen therapy (HBO) is approved for difficult-to-treat tissue injury. It also been used as a second-line treatment for refractory infection in hematologic malignancies. However, data on the efficacy of HBO in such population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2692cdcce82d816a04c147250aabb986
https://doi.org/10.1016/s2152-2650(21)01734-1
https://doi.org/10.1016/s2152-2650(21)01734-1
Autor:
Nicholas J. Short, Alessandra Ferrajoli, Zeev Estrov, Tapan M. Kadia, Yan Yuanqing, Hycienth Ahaneku, Elias Jabbour, Steven M. Kornblau, Farhad Ravandi, Bachar Samra, Koji Sasaki, Gautam Borthakur, Guillermo Garcia-Manero, Hagop M. Kantarjian, Jorge M. Ramos Perez, Jorge E. Cortes, Arrvind Raghunath, Ahmad S. Alotaibi, Veronica A Guerra, Nitin Jain, Guillaume Richard-Carpentier, Yasmin Alwash
Publikováno v:
Blood. 136:3-4
Background Unplanned 30-day readmissions are a frequent complication of acute leukemia therapy. However, there is limited data in acute lymphoblastic leukemia (ALL), with reported readmission rates (RaR) of 36% for pediatric ALL. Methods We retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f7c089e1d6c1f8724100bcdbe6773a0
https://doi.org/10.1182/blood-2020-142055
https://doi.org/10.1182/blood-2020-142055